A two-day immersive course crafted to equip participants with an in-depth understanding of remote audit methodologies. 2nd - 3rd June.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information30th April 2026
Summary:
The MHRA Safety Roundup for April 2026 highlights recent safety advice, emerging risks, and regulatory actions relating to medicines and medical devices in the UK. Key updates include guidance on the safe use of specific medicines, reporting of adverse drug reactions, and ongoing monitoring of product safety signals. The roundup reinforces the importance of vigilance among healthcare professionals and patients, encouraging continued reporting through the Yellow Card scheme to ensure timely identification of risks. It also reflects the MHRA’s ongoing commitment to transparency and proactive communication to safeguard public health.